Joseph D Schonoft

6PUBLICATIONS
79CO-AUTHORS
Molecular targetsPredictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 27, 2026
Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169.

Samir Zaidi, Phillip H Kuo, Tiago Paiva Prudente

|Jan 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.

Ezra Y Rosen, Timothy A Yap, Elisa Fontana

|Jul 24, 2025
Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response-Deficient Tumors.

Ian M Silverman, Joseph D Schonhoft, Benjamin Herzberg

|Jun 05, 2023
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.

Timothy A Yap, Elisa Fontana, Elizabeth K Lee

|Sep 15, 2017
Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.

Joseph D Schonhoft, Cecilia Monteiro, Lars Plate

Pageof 1